Compare Abbott India with WYETH LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs WYETH LTD - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA WYETH LTD ABBOTT INDIA/
WYETH LTD
 
P/E (TTM) x 48.2 27.7 173.9% View Chart
P/BV x 13.8 5.3 258.1% View Chart
Dividend Yield % 0.5 1.3 39.3%  

Financials

 ABBOTT INDIA   WYETH LTD
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
WYETH LTD
Mar-13
ABBOTT INDIA/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs6,1101,044 585.0%   
Low Rs3,996818 488.5%   
Sales per share (Unadj.) Rs1,552.2298.6 519.9%  
Earnings per share (Unadj.) Rs188.857.2 329.8%  
Cash flow per share (Unadj.) Rs196.458.4 336.3%  
Dividends per share (Unadj.) Rs55.0017.00 323.5%  
Dividend yield (eoy) %1.11.8 59.6%  
Book value per share (Unadj.) Rs796.6249.5 319.3%  
Shares outstanding (eoy) m21.2522.72 93.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.33.1 104.4%   
Avg P/E ratio x26.816.3 164.5%  
P/CF ratio (eoy) x25.715.9 161.4%  
Price / Book Value ratio x6.33.7 169.9%  
Dividend payout %29.129.7 98.1%   
Avg Mkt Cap Rs m107,37621,157 507.5%   
No. of employees `0003.30.5 675.2%   
Total wages/salary Rs m3,937400 984.2%   
Avg. sales/employee Rs Th9,929.313,787.4 72.0%   
Avg. wages/employee Rs Th1,185.1813.0 145.8%   
Avg. net profit/employee Rs Th1,207.72,643.3 45.7%   
INCOME DATA
Net Sales Rs m32,9856,783 486.3%  
Other income Rs m1,170353 331.8%   
Total revenues Rs m34,1557,136 478.6%   
Gross profit Rs m5,2451,617 324.3%  
Depreciation Rs m16227 608.6%   
Interest Rs m386 694.5%   
Profit before tax Rs m6,2151,938 320.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m2,203632 348.4%   
Profit after tax Rs m4,0121,301 308.5%  
Gross profit margin %15.923.8 66.7%  
Effective tax rate %35.432.6 108.6%   
Net profit margin %12.219.2 63.4%  
BALANCE SHEET DATA
Current assets Rs m22,6556,984 324.4%   
Current liabilities Rs m6,6812,056 325.0%   
Net working cap to sales %48.472.6 66.7%  
Current ratio x3.43.4 99.8%  
Inventory Days Days6599 65.3%  
Debtors Days Days2924 121.8%  
Net fixed assets Rs m835244 342.0%   
Share capital Rs m213227 93.5%   
"Free" reserves Rs m16,7155,441 307.2%   
Net worth Rs m16,9285,668 298.7%   
Long term debt Rs m025 0.0%   
Total assets Rs m24,1627,901 305.8%  
Interest coverage x163.7353.3 46.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.40.9 159.0%   
Return on assets %16.816.5 101.4%  
Return on equity %23.722.9 103.3%  
Return on capital %36.934.0 108.5%  
Exports to sales %00.2 0.0%   
Imports to sales %036.3 0.0%   
Exports (fob) Rs mNA15 0.0%   
Imports (cif) Rs mNA2,465 0.0%   
Fx inflow Rs m36915 2,424.6%   
Fx outflow Rs m3,8072,677 142.2%   
Net fx Rs m-3,438-2,662 129.2%   
CASH FLOW
From Operations Rs m1,527923 165.4%  
From Investments Rs m-2,148317 -677.9%  
From Financial Activity Rs m-1,024-481 213.0%  
Net Cashflow Rs m-1,646759 -216.8%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 51.1 146.8%  
Indian inst/Mut Fund % 7.9 11.3 69.9%  
FIIs % 0.1 7.2 1.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 30.4 56.3%  
Shareholders   18,270 21,978 83.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   PFIZER  GSK PHARMA  PLETHICO PHARMA  DR. REDDYS LAB  TORRENT PHARMA  

Compare ABBOTT INDIA With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Extend Gains; Tata Motors & ONGC Climb 5%(12:30 pm)

Share markets in India have extended early morning gains and are presently trading higher. Investors are cautious ahead of the release of Consumer Price Index-based inflation.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY19); Net Profit Up 70.8% (Quarterly Result Update)

Aug 20, 2018 | Updated on Aug 20, 2018

For the quarter ended June 2018, ABBOTT INDIA has posted a net profit of Rs 824 m (up 70.8% YoY). Sales on the other hand came in at Rs 8 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

What if Indiabulls Housing Finance and Yes Bank Do Not Rebound?(Profit Hunter)

Oct 1, 2019

How long should you wait for fallen blue chips like Yes Bank and Indiabulls Housing Finance to rebound?

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Foreign Money is Chasing Indian Stocks Once Again(The 5 Minute Wrapup)

Oct 4, 2019

Around Rs 75 billion poured into the Indian stock market in the month of September.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Oct 14, 2019 01:51 PM

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - JUBILANT LIFE SCIENCES COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS